Edgewise Therapeutics, Inc.EWTXNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-143.82M
↓ 121% vs avg
Percentile
P0
Near historical low
Streak
6 yr
Consecutive declineContracting
Average
$-64.96M
Historical baseline
PeriodValueYoY Change
2025$-143.82M-31.9%
2024$-109.03M-18.6%
2023$-91.95M-74.7%
2022$-52.63M-57.1%
2021$-33.51M-129.0%
2020$-14.63M-59.6%
2019$-9.17M-